Ruiz, Christian; Oeggerli, Martin; Germann, Markus; Gluderer, Silvia; Stocker, Hugo; Andreozzi, Mariacarla; Thalmann, George N; Cecchini, Marco G; Zellweger, Tobias; Stürm, Susanna; Koivisto, Pasi A; Helin, Heikki J; Gelmann, Edward P; Glass, Andrew G; Gasser, Thomas C; Terracciano, Luigi M; Bachmann, Alexander; Wyler, Stephen; Bubendorf, Lukas and Rentsch, Cyrill A (2012). High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth. Prostate, 72(15), pp. 1678-87. Hoboken, N.J.: Wiley-Blackwell 10.1002/pros.22521
Full text not available from this repository. (Request a copy)We recently established the rationale that NRBP1 (nuclear receptor binding protein 1) has a potential growth-promoting role in cell biology. NRBP1 interacts directly with TSC-22, a potential tumor suppressor gene that is differently expressed in prostate cancer. Consequently, we analyzed the role of NRBP1 expression in prostate cancer cell lines and its expression on prostate cancer tissue microarrays (TMA).
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology |
UniBE Contributor: |
Thalmann, George |
ISSN: |
0270-4137 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:38 |
Last Modified: |
05 Dec 2022 14:12 |
Publisher DOI: |
10.1002/pros.22521 |
PubMed ID: |
22473923 |
Web of Science ID: |
000309405800009 |
URI: |
https://boris.unibe.ch/id/eprint/15432 (FactScience: 222777) |
Actions (login required)
 |
Edit item |